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rotein degradation is irreversible, 
which makes it an attractive op-
tion for cells regulating crucial 
decisions. But for a biologist it sounds 
rather simplistically binary and dreary—
the protein is either destroyed or not 
destroyed. Michael Rape, a new faculty 
member at the University of California, 
Berkeley, CA, has found that ubiquitin-
mediated regulation and proteolysis is 
anything but dull.
Originally a biochemical oddity, ubiqui-
tination hit center stage when ubiquitin-
mediated cyclin destruction by the ana-
phase-promoting com-
plex (APC) was found 
to drive mitotic exit.
By the time Rape 
started his Ph.D. at the 
Max Planck (Martin-
sried, Germany), work 
on ubiquitin had 
branched out into 
discoveries of non-
destructive regulation. 
Rape’s colleagues in 
Stefan Jentsch’s lab 
had found that a 
ubiquit inated  tran-
scription factor called 
SPT23 could be clipped, but not de-
stroyed, by the proteasome (1). SPT23’s 
dimeric partner sheltered the clipped 
protein, preventing complete destruction.
But the partner’s continued grip 
stopped the nibbled protein from entering 
the nucleus. Rape found that the Cdc48 
complex came along to extract the short-
ened SPT23 from its dimeric complex, 
thus releasing it to enter the nucleus (2). 
For other extracted proteins, Cdc48 di-
rects them along a pathway leading to the 
protein-chewing proteasome (3).
Rape moved to Marc Kirschner’s lab 
at Harvard Medical School (Boston, MA), 
where he fi  gured out how the cell cycle 
gets restarted after mitosis. Once the APC 
has completely destroyed cyclin, it turns 
on itself to chew up one of its own com-
ponents (4). The resulting inactivity of 
APC explains why Rape’s G1 extracts 
failed to destroy cyclin A, and how cyclin 
levels are able to recover, only to activate 
the APC to continue the cycle.
Rape subsequently explored how APC 
substrates are destroyed in a defi  ned order. 
Those that disappear early get multiple 
ubiquitins from APC in one shot, whereas 
the slow customers wander away for 
cycles of deubiquitination in between 
ubiquitin additions (5).
He now hopes to screen for ubiquitina-
tion substrates using expression cloning. 
Past attempts featured simple cDNA li-
braries, in which regulatory cDNAs are 
underrepresented. A Unigene library 
(with each gene represented exactly once) 
now allows Rape to test smaller pools of 
cDNAs for their effects on protein degra-
dation in extracts. In a recent interview, 
he discussed this and other work he hopes 
to conduct at Berkeley.
BEGINNINGS
How did you ﬁ  rst get interested in 
science?
My great uncle had a very old pharmacy 
with a little lab in the back. When I was 
ten or eleven, I had my own lab in the 
basement doing chemistry experiments. I 
was born in an area where we had trouble 
with pollution—we had a lot of problems 
with SO2 in the air—so I tried to make 
SO2 in the lab. I gassed some plants and 
looked how they tried to survive.
What attracted you to Stefan Jentsch’s 
lab for your Ph.D.?
I liked the combination that he developed 
between genetics—fi   nding new compo-
nents—and understanding a mechanism.
Why did you think that degradation 
would be an interesting area to study?
In 1999, it was not like now where there is 
a big ubiquitin paper every week. I had 
the feeling that it was not completely 
solved yet—there were a lot of things to 
do. It turned out that ubiquitin was a very 
fruitful area, not only for learning a lot of 
different techniques and a lot of different 
approaches but also, in the end, how many 
different processes it controls. I really saw 
this when I looked for a postdoc position. 
I was more interested in questions of 
proliferation and differentiation, but their 
regulation brought me back very quickly 
to the ubiquitin.
You’ve described Cdc48 as a ubiquitin-
selective desegregase. When does the 
cell need such a function?
You need this if you want to extract only 
one subunit out of a complex. Cdc48 can 
get the subunit out and then attract pro-
teins that deubiquitinate it or can channel 
it to the proteasome. It’s a really crucial, 
central activity. It shows the power of 
ubiquitin as a cellular modifi  cation.
A FRUITFUL SIDETRACK
What was your initial aim in your 
postdoc?
I didn’t like the cell cycle too much be-
cause it seemed to be so complex with so 
many different groups competing in a 
relatively small area. I was more interest-
ed in the kinds of decisions that cells have 
to make during differentiation. These are 
very fundamental decisions and there are 
a lot of different layers of regulation.
Michael Rape
Michael Rape says that ubiquitination’s diversity and adaptability makes it 
an ideal entry point for understanding vast swaths of biology.
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(APC) activity in 
postmitotic brain 
cells, but nobody 
knew the pathway that the APC was 
regulating. My idea was to try to get an 
entry point into neuronal differentiation 
by finding the pathway regulated by 
the APC. I started with a degradation 
screen to fi  nd the important players. But 
my work turned out to go in a different 
direction.
When we tested human extracts with 
known substrates, the APC degraded 
some substrates like securin but we could 
never get other substrates like cyclin A 
to be degraded. We decided that before 
going on and screening this whole library, 
we actually should understand why the 
APC fails to degrade a couple of well-
known substrates.
That very quickly brought us back to 
the regulation of the APC, which we real-
ized wasn’t understood as well as people 
thought at the time. I kind of ended up 
back in the ubiquitin fi  eld as more a mat-
ter of chance than what I really intended 
to do when I looked for a postdoc.
Did the screen ever get done?
At the end of my postdoc, I turned back to 
this kind of question. We now have a sys-
tem where the APC can degrade substrates 
very, very effi  ciently. I am now in the pro-
cess of rerunning the screen and getting 
new substrates. With the new conditions, 
in vitro expression cloning is a very pow-
erful technique. We have more active ex-
tracts and much better negative controls, 
which allows a much more straightfor-
ward identifi  cation of substrates.
What else are you doing?
We are using in vivo sensors to measure 
the localization of degradation. We can 
test different mutations of the target sites, 
and couple this with an RNAi screen to 
identify regulators, seeing if we get more 
or less degradation or different local-
ization of degradation.
We want to do RNAi to identify ubiquitin 
ligases that control the entry to differen-
tiation. I’m also studying how deubiqui-
tination enzymes regulate the APC. I think 
the deubiquitination enzymes are probably 
just as interesting as ubiquitin ligases.
THE PROMISE OF UBIQUITIN
The ubiquitin ﬁ  eld is now far more 
crowded. Is there still growth potential?
There is huge potential. Although tremen-
dous progress has been made, a lot of 
fundamental questions in the fi  eld  still 
haven’t been answered. We have only begun 
to understand how important the chain 
length is, and how chains of different topol-
ogies are made and recognized. On both 
sides—the mechanistic questions and the 
substrates—there is a 
lot of potential.
After so long, why 
have these questions 
not been answered?
Ubiquitination is not 
a simple or trivial re-
action—it involves at 
least three different 
enzymatic activities. 
There is a lot of en-
zyme-specifi  c regula-
tion, so it has been 
hard to get paradigms 
for the whole fi  eld.
You always have 
two sides to it: the 
mechanism aspect on 
one side and the process that is controlled 
on the other side. Even though a lot of 
people are interested in the process that is 
controlled on the other side, substrate 
identifi  cation has been extremely diffi  cult. 
It took 15 years from the identifi  cation 
of Rad6 and the fact that ubiquitination 
was important for DNA repair to fi  nd 
probably the most important substrate in 
this process which turned out to be PCNA. 
It’s not trivial.
With all this diversity, how do you focus 
your studies?
One of my very strong interests is the 
mechanism of the ubiquitination, and 
how this mechanism is used to achieve a 
certain type of regulation. An example of 
this is how the APC orchestrates progres-
sion through mitosis using a mechanism 
akin to kinetic proofreading.
So does ubiquitin do every kind of 
regulation that you can ever imagine?
The fun about ubiquitin—this is some-
thing I really like about it—is that it can 
communicate a lot of information. You 
have monoubiquitination versus multi-
ubiquitination, there are different chains 
with different topologies, and all of them 
have different binding proteins. The whole 
system is reversible so you can add and 
remove. Really it’s something that can 
contain a lot of information.
We have probably around 1,000 
ubiquitin ligases in the genome, we have 
100 different deubiquitinating enzymes 
in the genome, and there are so many 
proteins that recognize ubiquitinated 
sites—still there are novel ubiquitin-
binding domains that are discovered on 
a regular basis. It’s not a surprise it can 
control so many processes.
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APC substrates (green) get chewed up at various different times.
“The fun about 
ubiquitin is 
that it can 
communicate 
a lot of 
information.”